GlaxoSmithKline update: influenza A (H1N1)

Commission seeks feedback on commitments offered by Sanofi over possible anticompetitive conduct regarding the promotion of a flu vaccine for vulnerable patients

Bird flu vaccine trial against potential pandemic strain begins

UVM study finds H1N1 and H3N2 flu viruses use different cellular entry routes, challenging long-held assumptions

Researchers at the University of Vermont's Larner College of Medicine have discovered that H1N1 and H3N2 influenza A strains use different c

Smart Analysis and Decision-Making for Emerging Infectious Diseases

FDA advisory panel recommends updating fall Covid vaccines to target XFG variant

An FDA advisory panel recommended updating fall 2025 Covid-19 vaccines to target the XFG variant ("stratus"), a fast-growing strain. The rec

Sanofi to Stop Disparaging Rival Flu Vaccine to Stave Off EU Antitrust Fine